Hypertrophic cardiomyopathy (HCM) is a clinically heterogeneous disease. Nevertheless, common underlying etiology can be identified among patients with HCM. In this educational program, three experts discuss the clinical characteristics and pathophysiology of HCM, challenges in the diagnosis and management, and therapeutic options for patients with HCM.
This course consists of 3 episodes. Watch all episodes, answer pre- and post-test questions, and start earning CME credits.
This educational program consists of three presentations on hypertrophic cardiomyopathy (HCM).
Hypertrophic cardiomyopathy: What are the concerns? - Antonis Pantazis, MD – London, UK
Diagnostic challenges for symptomatic obstructive HCM- Pablo García-Pavia, MD, PhD – Barcelona, Spain
Improving quality of life in patients with HCM - Carolyn Ho, MD – Boston, MA, USA
For questions regarding this activity, please contact us at info@medconinternational.com.
This educational activity is designed for all healthcare professionals with an interest in management of patients with HCM.
This online course is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credit.
Through an agreement between EBAC and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.
Funding for this educational program was provided by an unrestricted educational grant from Cytokinetics.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of PACE-cme.
Release Date:
Expiration Date:
